Cytotoxic molecules responsive to intracellular ligands for selective t cell mediated killing
AssigneeThe Regents of the University of California
InventorsYvonne Y. CHEN, Patrick HO
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Regents of the University of California
InventorsYvonne Y. CHEN, Patrick HO
Estimating the term…
Compositions and methods are provided for the cell-mediated targeted killing of diseased cells based on the presence of an intracellular antigen, rather than a surface-bound marker. The targeting cells are modified to express a cytotoxic protein that is delivered into a targeted cell, and after delivery is selectively activated by the presence of a cytoplasmic protein of interest. In one embodiment of the invention, the cytotoxic molecule is a Granzyme B (GrB) polypeptide. In the compositions of the invention, GrB is modified to render its cytotoxic enzymatic functions inactive, until the presence of an intracellular antigen unlocks the GrB molecule to enable enzymatic activities.
A cytotoxic protein modified to be inactive until brought into contact with an intracellular protein of interest.
Dependencies are inferred from the claim text.